FINWIRES · TerminalLIVE
FINWIRES

$LDOS

13 stories mentioning LDOSUpdated just now

Every FINWIRES story that references LDOS, newest first.

Wire

Leidos' Healthcare Business Sees Limited Future Upside From Increasing Competition, BofA Securities Says

Leidos' (LDOS) healthcare business sees limited future upside from increasing competition, BofA Securities said in a Wednesday note.BofA said it sees near-term pressure on the healthcare business as the U.S. Defense Health Agency seeks to work directly with suppliers in the Defense Health Management System Modernization program's maintenance phase.It also said the upcoming Medical Disability Examinations recompete could weigh on Leidos' future share and pricing power.The investment banking firm said it continues to recognize the value of Leidos' defense portfolio, but added that it does not believe investors will give credit for full value of the opportunities until the results begin to materialize.BofA downgraded Leidos to neutral from buy and adjusted its price target to $125 from $200.Price: $110.13, Change: $-3.45, Percent Change: -3.04%

$LDOS
Wire

Update: BofA Securities Downgrades Leidos to Neutral From Buy, Cuts Price Target to $125 From $200

(Updates to include BofA's commentary)BofA Securities Downgrades Leidos (LDOS) to neutral from buy, which reflects increasing pressure across what was once a blooming healthcare portfolio.The value of the company's defense portfolio and its strong alignment with DoW's priorities, including small cruise missiles, C2, counter UAS, hypersonics, and unmanned maritime solutions are still recognized but investors are unlikely to give credit for full value of the opportunities until the results begin to materialize, analysts led by Mariana Perez Mora wrote in a Wednesday note.Additionally, there are "no meaningful signs" of an accelerated sustained growth, the analysts mentioned.The analysts also cut Leidos' price target to $125 from $200.Leidos has an average rating of overweight and mean price target of $174.93, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $110.30, Change: $-3.29, Percent Change: -2.89%

$LDOS
Research

Update: BofA Downgrades Leidos Holdings to Neutral From Buy, Cuts Price Target to $125 From $200

(Updates with prior price target.)Leidos Holdings (LDOS) has an average rating of overweight and mean price target of $174.93, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$LDOS
Research

BofA Downgrades Leidos Holdings to Neutral From Buy, Price Target is $125

Leidos Holdings (LDOS) has an average rating of overweight and mean price target of $174.93, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$LDOS
Research

Jefferies Downgrades Leidos to Hold From Buy, Adjusts Price Target to $140 From $185

Leidos Holdings (LDOS) has an average rating of overweight and mean price target of $183.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$LDOS
Research

BNP Paribas Initiates Leidos Holdings at Outperform With $165 Price Target

Leidos Holdings (LDOS) has an average rating of overweight and mean price target of $186.27, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $131.89, Change: $+3.77, Percent Change: +2.94%

$LDOS
Wire

Leidos Wins $2.7 Billion US Army Contract for Hypersonic Weapons Production

Leidos Holdings (LDOS) won a $2.7 billion US Army contract to advance hypersonic weapons programs from prototyping to production.The award combines the Thermal Protection Shield and Common Hypersonic Glide Body programs, a move intended to streamline development and accelerate delivery for both the Army and the Navy, Leidos said Tuesday in a statement.The contract is expected to reduce production timelines and strengthen the supply chain for components, the company said.Price: $130.24, Change: $+2.56, Percent Change: +2.01%

$LDOS
Research

Research Alert: CFRA Maintains Hold Rating On Shares Of Leidos Holdings, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target price by $50 to $145, 11.2x our 2027 EPS estimate, vs. the peer average of 12.3x. We keep our 2026 EPS view unchanged at $12.30 and increase 2027's by $0.14 to $12.92. Reflecting strong business momentum, LDOS raised its full-year 2026 guidance, lifting revenue to a range of $18.0B-$18.4B (vs. $17.5B-$17.9B) and adjusted EPS to $12.10-$12.50 (vs. $12.05-$12.45). This confidence is driven by the successful execution of its NorthStar 2030 strategy, highlighted by the completed Entrust acquisition and a new security products joint venture. While facing temporary margin pressures from program delays and integration costs, these risks are offset by an exceptionally strong financial foundation, demonstrated by $301 million in Q1 operating cash flow. This, combined with 31% year-over-year growth in funded backlog of $9.6B and a healthy 1.1x trailing book-to-bill ratio, provides reasonable near-term revenue assurance.

$LDOS
Wire

Leidos Stock Continues to Face Pressure Over Uncertainty of Health, Defense Portfolios, RBC Capital Markets Says

Leidos (LDOS) posted a Q1 beat but uncertainty into 2027 over the health and defense portfolios continue to weigh on the stock, RBC Capital Markets said in a Tuesday research report.The health segment continues to normalize and margins remain robust as Veterans Affairs examination volumes are expected to remain elevated in 2026 as the agency focuses on burning backlog. Leidos is under contract to provide medical disability exams for the VA, but the company's contract awards and backlog visibility will take time to mature, analysts wrote.Leidos is making solid investments to position itself for market growth in 2027, but near-term outlook is likely to remain clouded, which will be an overhang on the stock, according to the note.The brokerage said it reiterated its outperform rating on the stock and cut its price target to $180 per share from $215.Price: $130.22, Change: $-6.97, Percent Change: -5.08%

$LDOS
Wire

TD Cowen Adjusts Price Target on Leidos Holdings to $160 From $175

Leidos Holdings (LDOS) has an average rating of overweight and mean price target of $193.08, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $132.12, Change: $-5.07, Percent Change: -3.70%

$LDOS
Research

Research Alert: Ldos Q1: Revenue Beat And Strong Cash Flow Counter Margin Compression

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:LDOS delivered solid Q1 results with adjusted EPS of $3.13 vs $2.97 prior year, beating consensus by $0.22. Revenue grew 4% Y/Y (+3% organic) to $4.40B, exceeding estimates by $110M, driven by Intelligence, commercial energy infrastructure, and air traffic management demand. The quarter's standout performance was exceptional cash generation, with operating cash flow reaching $301M vs $58M prior year and free cash flow improving to $270M from $36M, delivering 67% conversion driven by solid EBITDA generation and effective working capital management. However, adjusted EBITDA margin contracted 20 bps to 14.0% due to acquisition-related costs. Net bookings of $3.3B resulted in quarterly book-to-bill of 0.8x, though trailing-12-month ratio remained healthy at 1.1x. Total backlog reached $48.4B with funded backlog of $9.6B, representing 4% and 31% Y/Y growth respectively, providing enhanced revenue visibility going forward.

$LDOS
Sectors

Sector Update: Tech Stocks Advance Pre-Bell Tuesday

Technology stocks were higher pre-bell Tuesday, with the State Street Technology Select Sector SPDR ETF (XLK) gaining 0.8% and the State Street SPDR S&P Semiconductor ETF (XSD) 1.2% higher.Fidelity National Information Services (FIS) stock was up 5% after the company said it is working with Anthropic to create artificial intelligence tools for the banking industry, beginning with a financial crime agent.ServiceNow (NOW) shares were up more than 2% before the bell. A company presentation on Monday showed that ServiceNow is targeting up to $32 billion in subscription revenue by 2030 under an "upside" scenario.Leidos Holdings (LDOS) shares rose 2% in premarket activity after the company reported higher Q1 non-GAAP earnings and revenue.

$FIS$LDOS$NOW$XLK$XSD
Commodities

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Amid Corporate Earnings Rush

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.4% and the actively traded Invesco QQQ Trust (QQQ) advanced 0.6% in Tuesday's premarket activity amid a rush of corporate earnings.US stock futures were also higher, with S&P 500 Index futures up 0.4%, Dow Jones Industrial Average futures advancing 0.3%, and Nasdaq futures gaining 0.6% before the start of regular trading.International trade data for March will be released at 8:30 am ET, followed by S&P global services data for April at 9:45 am ET.ISM manufacturing data for April, job openings data for March, and new home sales data for March are all due at 10 am ET.Federal Reserve Vice Chair for Supervision Michelle Bowman and Fed Governor Michael Barr are slated to speak on Tuesday.In premarket activity, bitcoin was up by 1.1%. Among cryptocurrency ETFs, the cryptocurrency fund ProShares Bitcoin Strategy ETF (BITO) was 1.3% higher, Ether ETF (EETH) advanced 1%, and Bitcoin & Ether Market Cap Weight ETF (BETH) was flat.Power Play:IndustrialThe State Street Industrial Select Sector SPDR ETF (XLI) advanced 0.3%, while the Vanguard Industrials Index Fund (VIS) rose 1.7%, and the iShares US Industrials ETF (IYJ) was inactive.Sterling Infrastructure's (STRL) stock was up more than 25% before the opening bell after the company overnight reported a stronger-than-expected rise in Q1 earnings and sales, and guided fiscal 2026 sales above analyst expectations.Winners and Losers:ConsumerThe State Street Consumer Staples Select Sector SPDR ETF (XLP) gained 0.01% and the Vanguard Consumer Staples Index Fund ETF Shares (VDC) was up 0.6%. The iShares US Consumer Staples ETF (IYK) was inactive. The State Street Consumer Discretionary Select Sector SPDR ETF (XLY) advanced 0.3%. The VanEck Retail ETF (RTH) was inactive, while the State Street SPDR S&P Retail ETF (XRT) was 0.7% higher.Anheuser-Busch InBev (BUD) shares were up more than 6% pre-bell after the company reported higher fiscal Q1 underlying earnings and revenue.EnergyThe iShares US Energy ETF (IYE) was inactive, while the State Street Energy Select Sector SPDR ETF (XLE) was up by 0.1%.Kosmos Energy (KOS) stock was down more than 1% before the opening bell after the company reported a Q1 adjusted loss versus analysts' expectations of earnings.Health CareThe State Street Health Care Select Sector SPDR ETF (XLV) advanced 0.1%, the Vanguard Health Care Index Fund (VHT) gained 0.5%, while the iShares US Healthcare ETF (IYH) was flat. The iShares Biotechnology ETF (IBB) was 0.2% higher.IDEXX Laboratories (IDXX) stock was up more than 3% premarket after the company reported higher Q1 comparable earnings and revenue.FinancialThe State Street Financial Select Sector SPDR ETF (XLF) advanced 0.4%. Direxion Daily Financial Bull 3X Shares (FAS) was up 0.5%, while its bearish counterpart, Direxion Daily Financial Bear 3X Shares (FAZ), was 0.2% lower.HSBC (HSBC) shares were down more than 3% pre-bell after the company reported lower-than-expected Q1 earnings.TechnologyThe State Street Technology Select Sector SPDR ETF (XLK) gained 0.8%, and the iShares US Technology ETF (IYW) was flat, while the iShares Expanded Tech Sector ETF (IGM) was up 0.3%. Among semiconductor ETFs, the State Street SPDR S&P Semiconductor ETF (XSD) was 1.9% higher, while the iShares Semiconductor ETF (SOXX) rose by 1.4%.Leidos Holdings (LDOS) shares were up more than 2% in Tuesday's premarket activity after the company reported higher Q1 non-GAAP earnings and revenue.CommoditiesFront-month US West Texas Intermediate crude oil retreated by 2.4% to $103.92 per barrel on the New York Mercantile Exchange. Natural gas was down by 1.3% at $2.83 per 1 million British Thermal Units. The United States Oil Fund (USO) fell by 1.1%, while the United States Natural Gas Fund (UNG) was 0.8% lower.Gold futures for May gained by 0.9% to reach $4,573.50 an ounce on the Comex. Silver futures advanced by 0.9% to $74.20 an ounce. SPDR Gold Shares (GLD) was 1% higher, and the iShares Silver Trust (SLV) rose by 1.1%.

Dow JonesNasdaq CompositeS&P 500$BETH$BITO$BUD$EEM$EETH$EXI$FAS$FAZ$GLD$HSBC$IBB$IDXX$IGM$IGV$IPK$IVV$IWM$IYE$IYH$IYJ$IYK$IYW$KOS$LDOS$PMR$QQQ$RTH$SLV$SOXX$SPY$STRL$UNG$USO$VDC$VHT$VIS$XLE$XLF$XLI$XLK$XLP$XLV$XLY$XRT$XSD

Track with the FINWIRES app suite

FolioX
FolioX
Track LDOS in your portfolio
WheelAI
WheelAI
Analyze LDOS options with the wheel strategy
StockInsider
StockInsider
See market sentiment on LDOS